Literature DB >> 10512079

Effects of amphetamine on saccadic eye movements in man: possible relevance to schizophrenia?

S M Dursun1, N Wright, M A Reveley.   

Abstract

The antisaccade task can be used to test the voluntary control of saccadic eye movements (SEMs). In many disorders with postulated hyperdopaminergic neurotransmission, there are reports of abnormalities in SEMs. To further investigate this, the role of dopamine in SEMs, performance on an antisaccade task was examined in subjects with a history of amphetamine use (a dopamine releaser and reuptake inhibitor). A prospective design was employed in a teaching hospital setting. Six subjects (five males) with a history of amphetamine use were compared to 24 normal controls. None of the subjects were using any other substances, except alcohol and nicotine, as determined by urine screening, which we believe limited the sample size. For subjects who used amphetamine before the task, the presence of amphetamine was confirmed by urinalysis. All subjects completed the antisaccade task. Both error rates and latency rates during the antisaccade task were compared between the amphetamine users and controls. The amphetamine users had significantly increased error rates and latencies. These results may suggest that increased error rates and latencies during antisaccade tasks may be due to increased dopamine transmission, which is similar to the findings in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512079     DOI: 10.1177/026988119901300306

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  4 in total

1.  Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison.

Authors:  N Rycroft; S B Hutton; O Clowry; C Groomsbridge; A Sierakowski; J M Rusted
Journal:  Psychopharmacology (Berl)       Date:  2007-08-05       Impact factor: 4.530

Review 2.  Behavioural and computational varieties of response inhibition in eye movements.

Authors:  Vassilis Cutsuridis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

3.  Saccadic latency distributions in Parkinson's disease and the effects of L-dopa.

Authors:  A W Michell; Z Xu; D Fritz; S J G Lewis; T Foltynie; C H Williams-Gray; T W Robbins; R H S Carpenter; R A Barker
Journal:  Exp Brain Res       Date:  2006-03-17       Impact factor: 1.972

4.  Increased microsaccade rate in individuals with ADHD traits.

Authors:  Maria Panagiotidi; Overton Paul; Stafford Tom
Journal:  J Eye Mov Res       Date:  2017-03-04       Impact factor: 0.957

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.